Related Experiment Videos

Mad-related genes in the human

G J Riggins1, S Thiagalingam, E Rozenblum

  • 1Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.

Nature Genetics
|July 1, 1996
PubMed

Insights

Tumor cells often resist transforming growth factor-beta (TGF-β) signaling. Researchers identified novel human genes related to TGF-β signaling, with mutations found in colorectal cancers, suggesting a role in tumor suppression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Resistance to transforming growth factor-beta (TGF-β) is a hallmark of human cancers.
  • The mechanisms underlying TGF-β resistance in tumors are largely unknown.
  • TGF-β signaling pathways are crucial for regulating cell growth and differentiation.

Purpose of the Study:

  • To identify novel human genes involved in TGF-β signaling.
  • To investigate the potential role of these genes in cancer development and progression.
  • To explore the mechanisms of TGF-β resistance in neoplastic cells.

Main Methods:

  • Identification of novel human genes homologous to the Drosophila Mad gene.
  • Somatic mutation analysis in colorectal cancer samples.
  • Chromosomal localization of identified genes.

Main Results:

  • Five novel human genes related to the Drosophila Mad gene were identified.
  • Somatic mutations in one of these genes were detected in 2 out of 18 colorectal cancers.
  • Three of the identified genes were mapped to chromosomal regions previously associated with tumor suppressor activity.

Conclusions:

  • The identified gene family plays a significant role in TGF-β signal transduction.
  • Mutations and chromosomal alterations in these genes suggest their involvement in tumor suppression.
  • This gene family may be critical for mediating the growth inhibitory effects of TGF-β-like ligands and could be important in preventing neoplasia.

Related Concept Videos